|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Finance and other expenses | |||||
| Finance and other income | |||||
| Loss for the year before taxation | |||||
| Taxation | |||||
| Loss for the year after taxation | |||||
| Revenue | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Research and development costs | |||||
| General and administrative expenses | |||||
| Restructuring charges | |||||
| Operating loss | |||||
| Foreign currency (loss)/gain, net | |||||
| Other income, net | |||||
| Benefit from R&D credit | |||||
| Loss before income tax expense | |||||
| Income tax expense | |||||
| Net Loss | |||||
| Loss per share basic | |||||
| Loss per share diluted | |||||
| Weighted-average shares outstanding basic | |||||
| Weighted-average shares outstanding diluted |
Loading...
